Advanced Biomed Inc.
ADVB
$5.10
$0.357.37%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -20.40% | 210.64% | -14.90% | 97.44% | -19.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.41% | 41.59% | 0.75% | 72.08% | -23.87% |
| Operating Income | 8.41% | -41.59% | -0.75% | -72.08% | 23.87% |
| Income Before Tax | 59.17% | 1,308.32% | -45.67% | 13.32% | -13.38% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 59.17% | 1,308.32% | -45.67% | 13.32% | -13.38% |
| Earnings from Discontinued Operations | -- | 56.06% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 64.67% | 855.36% | -45.67% | 13.32% | -31.03% |
| EBIT | 8.41% | -41.59% | -0.75% | -72.08% | 23.87% |
| EBITDA | 6.33% | -109.45% | -13.91% | -108.48% | 17.72% |
| EPS Basic | 71.85% | 798.12% | -34.64% | 19.87% | -27.96% |
| Normalized Basic EPS | 67.46% | 45.06% | -34.64% | 19.87% | -10.73% |
| EPS Diluted | 71.85% | 798.12% | -34.64% | 19.87% | -27.96% |
| Normalized Diluted EPS | 67.46% | 45.06% | -34.64% | 19.87% | -10.73% |
| Average Basic Shares Outstanding | 25.48% | 8.20% | 8.20% | 8.17% | 2.40% |
| Average Diluted Shares Outstanding | 25.48% | 8.20% | 8.20% | 8.17% | 2.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |